SEC Form 4 · accession 0001179110-18-003317
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jared Watkin
Officer — Senior Vice President
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 28, 2018 | F | 3,866 | $60.55 | D | 69,511 | D | |
| Common shares without par value | Mar 1, 2018 | S | 426 | $58.851 | D | 69,085 | D | |
| Common shares without par value | Mar 1, 2018 | S | 200 | $58.855 | D | 68,885 | D | |
| Common shares without par value | Mar 1, 2018 | S | 370 | $58.902 | D | 68,515 | D | |
| Common shares without par valueF1 | holding | — | — | — | 494 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2018.
Remarks
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).